- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes eye diseases consist of a group of eye-related conditions that affect individuals with diabetes. The conditions include diabetic macular edema (DME), diabetic retinopathy, glaucoma, and cataract. Diabetes is the leading cause of eye diseases and can cause severe vision loss or blindness. These eye diseases are widely treated with laser surgery.
Scope of the Report:
This report focuses on the Diabetic Eye Disease Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The growing adoption of minimally invasive (MI) surgeries is one of the key growth drivers of the global diabetic eye disease devices market. As MI surgeries cause minimal scarring and have improved surgical outcomes, there is a significant reduction in the duration of hospital stay. Most retinal surgeries these days are carried out using an MI small gauge surgery that does not require sutures. Moreover, the MI surgical procedures are performed using the right-sized instruments that reduce post-operative discomfort. This results in facilitating rapid healing without changing the refractive power of the eye. Therefore, the MI approach is used in several retinal surgeries such as for the treatment of retinal detachment, macular holes, macular puckers, and diabetic maculopathy. The growing preference for minimally invasive retinal surgeries is expected to positively affect the market in the coming years.
The global diabetic eye disease devices market is highly competitive and characterized by the technological advancements and innovation. The market has several small and regional vendors developing strategic alliances with global players to gain market share. Factors like increased product portfolio extensions, advances in technology, and R&D have resulted in intense competition among vendors. The competition is expected to intensify with vendors using innovative marketing strategies to gain market presence.
The Americas to dominate the market and hold the largest market share of more than 55%. The US is the largest revenue generator in this region. According to the IDF estimates, 30 million people in the US had diabetes, which was the highest among 38 developed nations. Due to the increasing number of people with diabetes, there has been increasing incidences of eye disorders among the older population. Factors such as the recent technological advancements and awareness of laser eye surgeries will propel this market’s growth in the Americas.
The worldwide market for Diabetic Eye Disease Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Alcon Inc.
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Synergetics USA Inc.
Topcon Corp.
Abbott Medical Optics
Bausch & Lomb
Carl Zeiss Meditec
Lumenis
Meridian
NIDEK
Quantel
Rhein Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laser surgery
Vitrectomy
Market Segment by Applications, can be divided into
Hospitals
Clinics and laboratories
Others
There are 15 Chapters to deeply display the global Diabetic Eye Disease Devices market.
Chapter 1, to describe Diabetic Eye Disease Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diabetic Eye Disease Devices, with sales, revenue, and price of Diabetic Eye Disease Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetic Eye Disease Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diabetic Eye Disease Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diabetic Eye Disease Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Diabetic Eye Disease Devices Introduction
1.2 Market Analysis by Type
1.2.1 Laser surgery
1.2.2 Vitrectomy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics and laboratories
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alcon Inc.
2.1.1 Business Overview
2.1.2 Diabetic Eye Disease Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alcon Inc. Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ellex Medical Lasers Ltd.
2.2.1 Business Overview
2.2.2 Diabetic Eye Disease Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ellex Medical Lasers Ltd. Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 IRIDEX Corp.
2.3.1 Business Overview
2.3.2 Diabetic Eye Disease Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 IRIDEX Corp. Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Synergetics USA Inc.
2.4.1 Business Overview
2.4.2 Diabetic Eye Disease Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Synergetics USA Inc. Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Topcon Corp.
2.5.1 Business Overview
2.5.2 Diabetic Eye Disease Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Topcon Corp. Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Medical Optics
2.6.1 Business Overview
2.6.2 Diabetic Eye Disease Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Medical Optics Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bausch & Lomb
2.7.1 Business Overview
2.7.2 Diabetic Eye Disease Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bausch & Lomb Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Carl Zeiss Meditec
2.8.1 Business Overview
2.8.2 Diabetic Eye Disease Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Carl Zeiss Meditec Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lumenis
2.9.1 Business Overview
2.9.2 Diabetic Eye Disease Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lumenis Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Meridian
2.10.1 Business Overview
2.10.2 Diabetic Eye Disease Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Meridian Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 NIDEK
2.11.1 Business Overview
2.11.2 Diabetic Eye Disease Devices Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 NIDEK Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Quantel
2.12.1 Business Overview
2.12.2 Diabetic Eye Disease Devices Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Quantel Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Rhein Medical
2.13.1 Business Overview
2.13.2 Diabetic Eye Disease Devices Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Rhein Medical Diabetic Eye Disease Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetic Eye Disease Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Diabetic Eye Disease Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diabetic Eye Disease Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Diabetic Eye Disease Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Diabetic Eye Disease Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Diabetic Eye Disease Devices Market Analysis by Regions
4.1 Global Diabetic Eye Disease Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Diabetic Eye Disease Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Diabetic Eye Disease Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
4.3 Europe Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
4.5 South America Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
5 North America Diabetic Eye Disease Devices by Countries
5.1 North America Diabetic Eye Disease Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Diabetic Eye Disease Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Diabetic Eye Disease Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
5.3 Canada Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
6 Europe Diabetic Eye Disease Devices by Countries
6.1 Europe Diabetic Eye Disease Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Diabetic Eye Disease Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Diabetic Eye Disease Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
6.3 UK Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
6.4 France Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
6.5 Russia Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
6.6 Italy Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Diabetic Eye Disease Devices by Countries
7.1 Asia-Pacific Diabetic Eye Disease Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Diabetic Eye Disease Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Diabetic Eye Disease Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
7.3 Japan Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
7.4 Korea Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
7.5 India Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
8 South America Diabetic Eye Disease Devices by Countries
8.1 South America Diabetic Eye Disease Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Diabetic Eye Disease Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Diabetic Eye Disease Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Diabetic Eye Disease Devices by Countries
9.1 Middle East and Africa Diabetic Eye Disease Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Diabetic Eye Disease Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Diabetic Eye Disease Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
9.3 UAE Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Diabetic Eye Disease Devices Sales and Growth Rate (2013-2018)
10 Global Diabetic Eye Disease Devices Market Segment by Type
10.1 Global Diabetic Eye Disease Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Diabetic Eye Disease Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Diabetic Eye Disease Devices Revenue and Market Share by Type (2013-2018)
10.2 Laser surgery Sales Growth and Price
10.2.1 Global Laser surgery Sales Growth (2013-2018)
10.2.2 Global Laser surgery Price (2013-2018)
10.3 Vitrectomy Sales Growth and Price
10.3.1 Global Vitrectomy Sales Growth (2013-2018)
10.3.2 Global Vitrectomy Price (2013-2018)
11 Global Diabetic Eye Disease Devices Market Segment by Application
11.1 Global Diabetic Eye Disease Devices Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics and laboratories Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.1 Global Diabetic Eye Disease Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Diabetic Eye Disease Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.2.2 Europe Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.2.4 South America Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Diabetic Eye Disease Devices Market Forecast (2018-2023)
12.3 Diabetic Eye Disease Devices Market Forecast by Type (2018-2023)
12.3.1 Global Diabetic Eye Disease Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Diabetic Eye Disease Devices Market Share Forecast by Type (2018-2023)
12.4 Diabetic Eye Disease Devices Market Forecast by Application (2018-2023)
12.4.1 Global Diabetic Eye Disease Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Diabetic Eye Disease Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Diabetic Eye Disease Devices Picture
Table Product Specifications of Diabetic Eye Disease Devices
Figure Global Sales Market Share of Diabetic Eye Disease Devices by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
